Further reduction in EGFR signaling is supported by a recent study that revealed inhibition of N-glycosylation by tunicamycin in head and neck cancer cells inhibited tumorigenesis by triggering endoplasmic reticulum (ER) stress [44]. This evidence concerns the gene EGFR and head and neck cancer.